Probiota Asia

WATCH — Blackmores innovation chief hits out at 'health-washing' as firm ramps up probiotic efforts

This content item was originally published on, a William Reed online publication.

By Gary Scattergood

- Last updated on GMT

Related tags Probiotics Singapore Australia

'Health-washing' products with a sprinkling of probiotics risks drawing the sector into disrepute, and could threaten the concerted growth the industry is currently enjoying, claims Blackmores' director of product innovation.

NIA-GOED Omega-3 Summit

NutraIngredients, in conjunction with GOED, will be holding APAC's first ever omega-3 event in Singapore in February 2019, featuring renowned speakers from CSIRO, A*STAR, Koure, GOED and more.

Find out how to attend​.

Paul Mannion was a headline speaker at our recent Probiota Asia summit in Singapore, where he revealed details of the firm's probiotics strategy, and his take on the wider issues affecting the sector.

We caught up with him on camera, where he discussed his fears around commoditisation, and cited examples of probiotics being added to 'inherently unhealthy products'.

He also explained how Blackmores had recently ramped up its efforts in the probiotics space, and hinted at plans for a new range specifically for China, where the firm is keen to build its business in-market, alongside its thriving e-commerce channel.

Last but not least, after recently being elected president of Complimentary Medicines Australia (CMA), he reflected on some of the key priorities for the trade body.

Related news

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Follow us


View more